Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5030 total record number 58 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 30 out of 35
341 citations found

Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague

Albrecht, MT;Livingston, BD;Pesce, JT;Bell, MG;Hannaman, D;Keane-Myers, AM;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Functional determinants of human enteric -defensin HD5: crucial role for hydrophobicity at dimer interface

Rajabi, M;Ericksen, B;Wu, X;de Leeuw, E;Zhao, L;Pazgier, M;Lu, W;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • Synthesis of HD5 and Mutant Analogues:

    … Recombinant anthrax lethal factor was purchased from List Biological Laboratories, Inc. …

    LF Inhibition Kinetics:

    The inhibition of LF by various defensins was quantified using an enzymatic kinetic assay (52). Briefly, freshly prepared LF at a final concentration of 1 g/ml (10 nm) was incubated at 37 C for 30 min with a 2-fold dilution series of defensin in 20 mm HEPES buffer containing 1 mm CaCl2 and 0.5% Nonidet P-40, pH 7.2. 20 l of LF substrate (1 mm) was added to each well to a final concentration of 100 m in a total volume of 200 l. The enzyme activity, characterized as a time-dependent absorbance increase at 405 nm due to the release of p-nitroaniline, was monitored at 37 C over a period of 5 min on a 96-well Vmax microplate reader …

    Author did not indicate which specific lethal factor was utilized.  List Labs provides Product #172 (Anthrax Lethal Factor (LF), Recombinant from B. anthracis) and Product #169 (Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence).

The Skp chaperone helps fold soluble proteins in vitro by inhibiting aggregation

Entzminger, KC;Chang, C;Myhre, RO;McCallum, KC;Maynard, JA;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Molecular and biological characterization of Streptococcal SpyA-mediated ADP-ribosylation of intermediate filament protein vimentin

Icenogle, LM;Hengel, SM;Coye, LH;Streifel, A;Collins, CM;Goodlett, DR;Moseley, SL;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization

Smith, K;Crowe, SR;Garman, L;Guthridge, CJ;Muther, JJ;McKee, E;Zheng, NY;Farris, AD;Guthridge, JM;Wilson, PC;James, JA;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Invariant gly residue is important for -defensin folding, dimerization, and function: a case study of the human neutrophil -defensin HNP1

Zhao, L;Ericksen, B;Wu, X;Zhan, C;Yuan, W;Li, X;Pazgier, M;Lu, W;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • Synthesis and Folding of Defensins:

    Recombinant LF was purchased from List Biological Laboratories, Inc.

    LF Activity Inhibition by l-Ala17-HNP1 Was Less Than Wild-type HNP1:

    The enzyme activity of LF in the presence of HNP1 or l-Ala17-HNP1 was assessed using a method adapted from Kaufmann and colleagues (30). Fig. 7 shows that the inhibitory activity of l-Ala17-HNP1 as measured by the concentration that gave 50% inhibition (IC50) differed slightly more than 2-fold compared with HNP1. By contrast, d-Ala17-HNP2 (HNP1 numbering) was equally active compared with HNP2. The d-Ala17 mutation was incorporated into HNP2 instead of HNP1 to conform to the previous study (18), but because HNP1 and HNP2 vary only by the deletion of a single Ala residue at the N terminus, they should be comparable with one another with respect to the internal Gly17 residue. LF inhibition is impaired only by the Gly17 to l-Ala17 mutation but not the Gly17 to d-Ala17 mutation, pointing to a local structural defect as the culprit.

    Author did not indicate which specific lethal factor was utilized.  List Labs provides Product #172 (Anthrax Lethal Factor (LF), Recombinant from B. anthracis) and Product #169 (Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence).

Sortase-conjugation generates a capsule vaccine that protects guinea pigs against Bacillus anthracis

Garufi, G;Wang, YT;Oh, SY;Maier, H;Missiakas, DM;Schneewind, O;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Empirical methods for identifying specific peptide-protein interactions for smart reagent development

Kogot, JM;Sarkes, DA;Stratis-Cullum, DN;Pellegrino, PM;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Cluster cytometry for high-capacity bioanalysis

Edwards, BS;Zhu, J;Chen, J;Carter, MB;Thal, DM;Tesmer, JJ;Graves, SW;Sklar, LA;

Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence